Results 131 to 140 of about 26,198 (235)

Evaluation of the Cutaneous Immunological Milieu Before and After Treatment With Meglumine Antimoniate in Dogs Naturally Affected by Leishmaniosis due to Leishmania infantum

open access: yesVeterinary Dermatology, Volume 37, Issue 3, Page 455-463, June 2026.
Background: Canine leishmaniosis (CanL) is a zoonotic disease of variable severity. The typical immune response is driven by an exaggerated humoral immune response. Protective immunity is mediated by pro‐inflammatory cytokines that enhance macrophage leishmanicidal activity. Objective: To evaluate the cutaneous and the systemic immune responses as well
M. Platenik   +5 more
wiley   +1 more source

Therapeutic Effects of Allopurinol on Left Ventricular Function in Patients with Chronic Heart Failure

open access: yesپزشکی بالینی ابن سینا, 2010
Introduction & Objective: Heart failure that is a major health problem with increasing incidence with the aging of the population often occurs as a result of ischemia and coronary artery disease.
Alireza Rai   +3 more
doaj  

Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients

open access: yesBMC Medical Genomics
Background Allopurinol has been causing substantial morbidity and mortality particularly in Asian population by producing cutaneous adverse drug reactions (cADRs).
Gaidganok Sornsamdang   +19 more
doaj   +1 more source

Effect of Systemic Antioxidant Allopurinol Therapy on Skin Flap Survival

open access: yes, 2017
BACKGROUND It has been reported that systemic administration of allopurinol improves cell survival. This study was aimed to evaluate effects of allopurinol on skin flaps in dogs. METHODS Twenty dogs underwent one skin flap surgery with a 2-week interval.
Al-Dam, A.   +3 more
core  

Allopurinol encapsulated in polycyanoacrylate nanoparticles as potential lysosomatropic carrier

open access: yes, 2000
The activity of allopurinol-loaded polyethylcyanoacrylate nanoparticles against Trypanosoma cruzi was compared to that of free allopurinol using in vitro cultures of epimastigotes.
Osuna, A   +3 more
core  

Interaction of allopurinol with human blood

open access: yes, 1980
Even though allopurinol has been on the market for over fifteen years,for use in the treatment of gout and other forms of hyperuricemia, relatively few studies have been reported on the pharmacokinetics of this drug in man.
Thomas, George
core  

Benchmarking untargeted metabolomics data quality with allopurinol-induced perturbations. [PDF]

open access: yesMetabolomics
Vasskog T   +5 more
europepmc   +1 more source

Polydatin alleviates adenine-induced nephropathy in mice. [PDF]

open access: yesRen Fail
Sheng T   +11 more
europepmc   +1 more source

Allopurinol has no effect on calcitriol or other CKD-MBD biomarkers: a randomized double-blind study. [PDF]

open access: yesJ Endocr Soc
Costa TE   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy